JNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer Lawsuits
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Johnson & Johnson stock is up on Wednesday as JNJ investors learn of plans for a $6.5 billion settlement to its talc lawsuits.
The post JNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer Lawsuits appeared first on InvestorPlace.
More From InvestorPlace